ArticleInteractive journal of medical research2026
Real‑World Clinical Characterization of Major Depressive Disorder and Treatment‑Resistant Depression Supported by Natural Language Processing: Multicenter Observational Study From the MOOD Project.
Article in Interactive journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMajor depressive disorder (MDD) and treatment-resistant depression (TRD) are heterogeneous conditions in which key clinical details are split across structured fields and free-text notes in electronic health records (EHRs), constraining population-level insight and timely audit of care quality.
objectiveThis study aims to present a clinician-oriented, artificial intelligence-supported real-world evidence (RWE) methodology integrating structured and unstructured EHR data to profile MDD and TRD, and report comorbidity patterns from a 2-site pilot. This analysis reports the first objective of the MOOD project, which is to characterize the real‑world clinical and disease severity profile of patients with MDD and treatment‑resistant depression, providing a necessary foundation for subsequent evaluations of treatment patterns and outcomes.
methodsWe conducted a retrospective study in 2 Belgian hospitals (September 2021-June 2023). Adults (aged ≥18 years) with MDD were identified via DSM-IV (Diagnostic and Statistical Manual of Mental Disorders [Fourth Edition]) and ICD-10 (International Statistical Classification of Diseases, Tenth Revision) codes or natural language processing-detected note mentions; bipolar depression was excluded. TRD was defined as initiation of a third distinct antidepressant, supplemented by explicit mentions of TRD in notes. Structured data (demographics, diagnoses, medications, and hospitalizations) were harmonized in an Observational Medical Outcomes Partnership warehouse. Free-text notes were processed with a natural language processing pipeline to capture symptoms, psychiatric comorbidities, and contextual events.
resultsWe identified 1147 adults with MDD, of which 46% (524/1147) met TRD criteria. Females comprised 62.9% (722/1147) and mean (SD) age was 57.8 (18.4) years. Mortality was 13.3% (152/1147) overall (57/1147, 10.9% TRD vs 95/1147, 15.2% non-TRD). Common medical comorbidities were central nervous system diseases (477/1147, 41.6%) and heart diseases (349/1147, 30.4%). Dementia was more frequent in TRD (42/1147, 8% vs 32/1147, 5.1%), whereas obesity was higher in non-TRD (70/1147, 11.2% vs 46/1147, 8.8%). Anxiety disorder occurred in 35.4% (406/1147) overall and was more prevalent in TRD (229/1147, 43.7% vs 177/1147, 28.4%); personality and panic disorders also trended higher. Severity was sparsely documented (severe MDD 170/1147, 14.8%) and standardized scales were rarely recorded.
conclusionsWe present a step-by-step artificial intelligence-supported methodology tailored for clinicians, discussing challenges in integrating RWE into psychiatry, and identifying opportunities to enhance data collection with minimal workflow changes, which emphasizes the transformative potential of RWE systems in mental health research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.